# CEST-based Biomarkers to Delineate the Epileptogenic Zone

> **NCT07316972** · NA · NOT_YET_RECRUITING · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 20 (estimated)

## Conditions studied

- Epilepsy (Treatment Refractory)

## Interventions

- **OTHER:** CEST sequence on a 7-Tesla MRI

## Key facts

- **NCT ID:** NCT07316972
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07316972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07316972, "CEST-based Biomarkers to Delineate the Epileptogenic Zone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07316972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*